{"SPADE_N_05542": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_05542", "Peptide Name": "Enterocin 7B (Bacteriocin)", "Source": "Enterococcus faecalis 710C; Enterococcus faecalis MRR 10-3", "Family": "Belongs to the class IId bacteriocin", "Gene": "mr10B", "Sequence": "MGAIAKLVAKFGWPFIKKFYKQIMQFIGQGWTIDQIEKWLKRH", "Sequence Length": 43, "UniProt Entry": ["http://www.uniprot.org/uniprot/Q1A2D2"], "Protein Existence": "", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "broad-spectrum( mainly Gram-positive)", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Cell membrane", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Both peptides are primarily alpha-helical, adopting a similar overall fold. The structures can be divided into three separate alpha-helical regions: the N- and C-termini are both alpha-helical, separated by a central kinked alpha-helix. The overall structures bear an unexpected resemblance to carnocyclin A, a 60-residue peptide that is cyclized via an amide bond between the C- and N-termini and has a saposin fold.", "Formula": "C250H380N62O54S2", "Mass": 5182.2, "PI": 10.22, "Net Charge": 7, "Hydrophobicity": -0.11, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Comments": "leaderless, i.e. no signal peptide. Although MR10B and Enterocin 7B share the same amino acid sequence, enterocin 7B is N-terminally formylated Met.  Remarkably, the peptides are helical in aqueous solution. Enterocins 7A and 7B each display strong activity by themselves without their partner.", "Literature": [{"Title": "Identification of an N-terminal formylated, two-peptide bacteriocin from Enterococcus faecalis 710C.", "Pubmed ID": "21469734", "Reference": "J Agric Food Chem. 2011 May 25;59(10)5602-8.", "Author": "Liu X, Vederas JC, Whittal RM, Zheng J, Stiles ME, Carlson D, Franz CM, McMullen LM, van Belkum MJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21469734"}, {"Title": "Solution structures of the linear leaderless bacteriocins enterocin 7A and 7B resemble carnocyclin A, a circular antimicrobial peptide.", "Pubmed ID": "23725536", "Reference": "Biochemistry. 2013 Jun 11;52(23)3987-94.", "Author": "Lohans CT, Towle KM, Miskolzie M, McKay RT, van Belkum MJ, McMullen LM, Vederas JC.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23725536"}], "Frequent Amino Acids": "KIF", "Absent Amino Acids": "CNOSU", "Basic Residues": 9, "Acidic Residues": 2, "Hydrophobic Residues": 23, "Polar Residues": 19, "Positive Residues": 9, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00144", "Similarity": 0.9534883720930233, "Sequence": "MGAIAKLVTKFGWPLIKKFYKQIMQFIGQGWTIDQIEKWLKRH"}, {"SPADE_ID": "SPADE_N_00143", "Similarity": 0.7441860465116279, "Sequence": "MGAIAKLVAKFGWPIVKKYYKQIMQFIGEGWAINKIIEWIKKHI"}, {"SPADE_ID": "SPADE_N_05543", "Similarity": 0.7441860465116279, "Sequence": "MGAIAKLVAKFGWPIVKKYYKQIMQFIGEGWAINKIIDWIKKHI"}]}}}